BOSTON and ROLLE, Switzerland, Aug. 5, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types of breast cancer. It will also support the potential development of a bespoke AI-powered predictive model aimed at optimizing outcomes for indivi
Funding to accelerate the expansion of Uzbekistan's leading fintech platform and e-commerce ecosystem Uzum raises nearly $70 million in equity financing led by Tencent and VR Capital, with participation from FinSight Ventures Uzum's valuation surges to ~$1.5 billion post-money, reflecting the company's rapid growth across fintech and e-commerce Uzum Bank has emerged as the fastest-growing digital bank in Uzbekistan, issuing over 2 million co-branded Visa debit cards with embedded credit limits Fintech services deeply integrated with Uzum's e-commerce ecosystem Fresh c
RIYADH, Saudi Arabia, Aug. 5, 2025 -- The Saudi Ministry of Finance welcomed the report of the 2025 Article IV consultations with the Kingdom of Saudi Arabia that was issued recently by the International Monetary Fund (IMF). The report noted the Kingdom's resilience and strong ability to face external economic shocks and challenges, as well as the continued expansion of its non-oil economic activities, its ability to contain inflation, and the decline in the unemployment rate to its lowest levels in history. The report highlighted the efforts made in disclosin
DONGGUAN, China, Aug 5, 2025 -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollment in China for its Phase I clinical trial of FP008 , a first-in-class immunotherapy for solid tumors, at Zhejiang Cancer Hospital. The patient has completed the Dose Limiting Toxicity (DLT) observation period with a favorable safety profile. The trial aims to evaluate the safety and tolerability of FP008 in patients with advanced solid tumors. As the latest next generation of immuno-oncology (IO) app
[ 메디채널 황정호 기자 ] PEOPLE FROM 109 COUNTRIES INVEST IN SHARJAH IN H1 – INDIAN, SYRIAN INVESTORS LEAD SHARJAH, UAE, Aug. 5, 2025 -- Real estate transactions in the emirate of Sharjah surged to $7.3 billion in the first half of 2025, up 48.1% from $4.9 billion in the same period last year, according to Sharjah Real Estate Registration Department. The number of transactions rose to over 48,000, a 3.3% increase from 2024. Investors from 109 nationalities participated, reflecting Sharjah's growing appeal as a global real estate destination, driven by diverse property offerings, advanc
マニラ(フィリピン)、2025年8月5日 -- ASEANで最も歴史のあるコングロマリットのひとつであるAyala Corporationは、2025年ASEANコーポレート・ガバナンス会議およびアワード(2025 ASEAN Corporate Governance Conference and Awards)において、コーポレート・ガバナンスに優れた企業として、ASEAN地域の上場企業トップ50、フィリピンではトップ5に選ばれました。 Ayalaは、事業の透明性と説明責任、取締役会の実効性、持続可能性、ステークホルダー・エンゲージメントにおいて世界最高水準にあり、世界トップクラスのコーポレート・ガバナンスを実践しています。 「Ayalaは、卓越したコーポレート・ガバナンスが、人々の繁栄を可能にするビジネスを構築するという目的に沿った、目的を持った意思決定プロセスと行動を可能にすると信じています。同時に、強固なガバナンス倫理は投資家の関心と信頼を維持する鍵でもあります。当社は、このたびの評価を心から光栄に思います。この栄誉ある賞は、すべてのステークホルダーの利益のために、誠実さ、透明性、説明責任をもって事業を行う努力を続ける上で大きな励みとなります」と、Ayala Corporationの最高法務責任者兼コンプライ
GUANGZHOU, China, Aug. 5, 2025 -- Sunshine Lake Pharma Co., Ltd. (06887.HK) announced that the company will officially list on the Hong Kong Stock Exchange on August 7th. Through this integration, the company has effectively combined its expertise in drug R&D with the mature nationwide sales network resources of Sunshine Lake Pharma Co., Ltd. This forms an R&D-manufacturing-sales closed loop to accelerate global operations, thereby driving value reshaping and laying a more solid foundation for future sustainable development, including international expansion. This year, propell
SYDNEY, Aug. 5, 2025 -- VT Markets' 10 week global trading competition, VT Trading Arena, has reached new milestones, reinforcing its status as one of the premier global trading events of the year as traders compete for a share of the remarkable USD1,000,000 prize pool. The VT Trading Arena has witnessed an overwhelming global response, attracting traders of all experience levels. This impressive turnout reflects the international appeal of the competition, which has united traders from various regions and backgrounds. - Total Trading Volume Surpasses USD2B in the
[ 메디채널 황정호 기자 ] シドニー、2025年8月5日 -- VT Marketsの10週間のグローバル・トレーディング・コンペティション、VTトレーディング・アリーナ(VT Trading Arena)は新たな節目を迎え、賞金総額100万米ドルという驚異的な賞金プールを懸けてトレーダーたちが競い合う、本年度を代表するグローバル・トレーディング・イベントとしての地位をより強固なものにしています。 VTトレーディング・アリーナ(VT Trading Arena)は、あらゆる経験レベルのトレーダーを魅了し、世界的に圧倒的な反響を呼んでいます。この印象的な動員数は、さまざまな地域や背景を持つトレーダーが団結した、この大会の国際的な魅力を反映しています。 - 最初の4週間で総取引高が20億米ドルを突破:この莫大な取引は、参加者が真剣勝負を挑んでいること、そしてこのイベントを特徴づける競争心を明確に反映しています。- 最も取引されているシンボル:このコンペティションで最も取引されたシンボルは、世界のトレーダーの戦略に関する貴重な知見を明らかにしています。EUR/USD、GBP/USD、USD/JPYといった取引量の多いFXペアがリーダーボードを独占しています。このように主要通貨ペアに戦略的に焦点を当てることは、効果的な取引戦略を形成する
BANGKOK, Aug. 4, 2025 -- Chugai Pharma Taiwan (CPT), a subsidiary of Chugai Pharmaceutical Co., Ltd. in Japan, has been recognized in both the Social Empowerment and Green Leadership categories at the Asia Responsible Enterprise Awards (AREA) 2025. These recognitions highlight the company's exceptional efforts in driving community impact and environmental sustainability through healthcare-focused innovation and compassion. In the Social Empowerment category, CPT was recognized for its heartfelt and impactful charitable initiatives. Through its annual charity cycling event, CPT not only